In an interview this week, National Institutes of Health director and Human Genome Project veteran Francis Collins opens up to Nature's Meredith Wadman on his four years leading the NIH as one-time windfalls from the American Recovery Act have withered into what he calls "about a 20 percent loss in buying power over the last ten years."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Greener Pastures

Hoping for More

Do It Again

And the Result Is…

All the Generations

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.